Onconetix, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Onconetix, Inc. (ONCO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.77 million shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2024-04-11
- Onconetix, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 15.77M shares, a 136.91% increase from fiscal 2022.
- Onconetix, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.66M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2023-12-31 | 15.77M shares 10-K · filed 2024-04-11 |
| 2022-12-31 | 6.66M shares 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |